Skip to main content
. Author manuscript; available in PMC: 2016 May 4.
Published in final edited form as: Prostate. 2014 Jun 9;74(11):1118–1131. doi: 10.1002/pros.22828

Fig. 5.

Fig. 5

(A) β-Catenin and ligand (R1881)-bound wild type AR, but not DNA-binding AR mutant A573D, co-immunoprecipitate (IP) with nuclear TCF-4 in PrEC-hTERT-LV-AR cells. Non-specific IgG antibody was used as a negative control. (B) Immuno-histochemical staining of active β-catenin in PrEC-hTERT-LV-AR cells.